Polymyositis Progression: Phases, Symptoms, and Management Outlook

Polymyositis (PM) is an idiopathic inflammatory myopathy with variable progression. Four clinical phases are recognized, though not all patients experience each distinctly.

Phase 1: Early/Subacute Onset

• Proximal muscle weakness (hips, thighs, shoulders)—difficulty rising, climbing stairs, lifting.
• Fatigue, low-grade fever, myalgias.
• Symmetrical pattern; distal muscles spared initially.
• Duration: weeks to months.

Phase 2: Active/Progressive

• Weakness extends to more muscle groups; functional impairment escalates.
• Dysphagia (esophageal involvement) → aspiration risk.
• Respiratory muscle weakness → dyspnea, reduced vital capacity.
• Extramuscular: arthritis, Gottron's papules (knuckles), heliotrope rash (periorbital), mechanic's hands.
• Interstitial lung disease (ILD) may emerge—major mortality driver.

Phase 3: Plateau/Stabilization

• Symptoms stabilize with treatment; residual weakness varies.
• Some achieve near-normal function; others plateau with significant disability.
• Ongoing immunosuppression typically required.

Phase 4: Chronic/Refractory

• Persistent weakness, muscle atrophy, contractures.
• Complications: ILD progression, cardiomyopathy, calcinosis, malignancy association (age-appropriate screening).
• Treatment resistance requires escalation (IVIG, rituximab, JAK inhibitors, transplant evaluation).

Prognostic Factors

Early diagnosis, prompt immunosuppression, ILD absence, and younger age predict better outcomes. Multidisciplinary care (rheumatology, pulmonology, physiatry) optimizes long-term function.